Issue navigation
Volume 5, Issue 3, July 2023
Invited Editorial
Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otac031, https://doi.org/10.1093/crocol/otac031
Intestinal Ultrasound Is the Ideal Patient-Centric, Point-of-Care Tool for Clinical Decision Making in the Inflammatory Bowel Disease Practice
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad029, https://doi.org/10.1093/crocol/otad029
Golimumab for Ulcerative Colitis: One More Option to SAVE the Colon
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad046, https://doi.org/10.1093/crocol/otad046
Hot Topic Review
Health Communication Research Informs Inflammatory Bowel Disease Practice and Research: A Narrative Review
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad021, https://doi.org/10.1093/crocol/otad021
Innovations in Care Delivery
Clinician Adherence to Inflammatory Bowel Disease Guidelines: Results of a Qualitative Study of Barriers and Enablers
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otac018, https://doi.org/10.1093/crocol/otac018
Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad043, https://doi.org/10.1093/crocol/otad043
Observations and Research
Economic Burden of Fatigue in Inflammatory Bowel Disease
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad020, https://doi.org/10.1093/crocol/otad020
A Decade of Waiting: Experiences of Women Living With Vulvar Crohn’s Disease and Interactions With Healthcare Professionals Related to Their Sexual Well-Being: A Qualitative Study
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad025, https://doi.org/10.1093/crocol/otad025
Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad026, https://doi.org/10.1093/crocol/otad026
Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled Study
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad022, https://doi.org/10.1093/crocol/otad022
Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn’s Disease: Is There Any Difference between Small Intestine and Colonic Lesions?
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad028, https://doi.org/10.1093/crocol/otad028
IgA Determines Bacterial Composition in the Gut
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad030, https://doi.org/10.1093/crocol/otad030
Utility of Intestinal Ultrasound in Clinical Decision-Making for Inflammatory Bowel Disease
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad027, https://doi.org/10.1093/crocol/otad027
Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad032, https://doi.org/10.1093/crocol/otad032
Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad031, https://doi.org/10.1093/crocol/otad031
Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United States
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad033, https://doi.org/10.1093/crocol/otad033
Epidemiology, Disease Course, and Clinical Outcomes of Perianal Fistulas and Fissures Crohn’s Disease: A Nationwide Population-Based Study in Taiwan
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad035, https://doi.org/10.1093/crocol/otad035
Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad039, https://doi.org/10.1093/crocol/otad039
The Impact of Crohn’s Perianal Fistula on Quality of Life: Results of an International Patient Survey
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad036, https://doi.org/10.1093/crocol/otad036
Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad037, https://doi.org/10.1093/crocol/otad037
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad034, https://doi.org/10.1093/crocol/otad034
Watchful Waiting After Radiological Guided Drainage of Intra-abdominal Abscess in Patients With Crohn’s Disease Might Be Associated With Increased Rates of Stoma Construction
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad038, https://doi.org/10.1093/crocol/otad038
Pyoderma Gangrenosum Is Associated With Increased Risk of Inflammatory Pouch-Related Complications: A Retrospective Cohort Study
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad024, https://doi.org/10.1093/crocol/otad024
Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad045, https://doi.org/10.1093/crocol/otad045
IBD Camp Oasis: A look at Participants’ Social-Emotional Well-Being and Protective Factors During Camp and Beyond
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad042, https://doi.org/10.1093/crocol/otad042
Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and Long-Term Extension Studies
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad044, https://doi.org/10.1093/crocol/otad044
Case Proceedings
A Masking Effect: A Case of Initial Presentation of Ulcerative Colitis After Discontinuing Growth Hormone Therapy
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad041, https://doi.org/10.1093/crocol/otad041
Fellows' Corner
Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad047, https://doi.org/10.1093/crocol/otad047
Correction
Correction to: Watchful Waiting After Radiological Guided Drainage of Intra-abdominal Abscess in Patients With Crohn’s Disease Might Be Associated With Increased Rates of Stoma Construction
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad049, https://doi.org/10.1093/crocol/otad049
